CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 100 enrolled
Drug / intervention
Methylprednisolone; hydrocortisone +1 moredrug
Likely dose
Methylprednisolone; hydrocortisone 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02790788
NCT02790788Phase 2Completed

Physiologic Effects of Stress Dose Corticosteroids in the Management of Inhospital Cardiac Arrest - CORTICA

University of Athens·interventional·Posted Jun 6, 2016·Updated Nov 23, 2021

In Brief

A Phase 2 clinical trial evaluating Methylprednisolone; hydrocortisone and Saline Placebo for Inhospital Cardiac Arrest. Completed, enrolled 100 participants across 2 sites.

Detailed Summary

Early stress-dose steroids are of uncertain efficacy in cardiac arrest. The current authors plan to conduct a prospective, randomized, placebo controlled evaluation of stress-dose steroids efficacy with repect to early postresuscitation hemodynamics, heart function, brain perfusion, and inflammatory response in vasopressor-requiring cardiac arrest. Patients will also be followed for organ dysfunction, potential, steroid-associated complications, and functional outcome at hospital discharge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGreece

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJun 6, 2016
Enrollment StartNov 4, 2016
Primary CompletionMay 22, 2018
Study CompletionAug 11, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.1 years ago

Interventions

Methylprednisolone; hydrocortisonedrug

Methylprednisolone 40 mg during resuscitation and stress-dose hydrocortisone for postresuscitation shock

Saline Placebodrug

Saline placebo during resuscitation and during the postresuscitation phase.